The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
In this story
Coverage
1 publication is covering this story.
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.